Sandoz SA (Pty) Ltd., a prominent player in the pharmaceutical sector, operates from South Africa and engages actively in global trade, with strong procurement networks and export partnerships. In this article, we dive into detailed insights into their business operations, procurement strategies, supply chain, and partners using reliable data from NBD DATA. This analysis helps understand Sandoz SA (Pty) Ltd. and its presence in international trade, particularly regarding pharmaceutical ingredients and products.

Sandoz SA (Pty) Ltd. Overview

Sandoz SA (Pty) Ltd. operates at 2173-1177 Magwa Cres, Midrand, 2066, South Africa, and is a subsidiary of Sandoz International, a global leader in generics and biosimilars. Their international outreach involves both import and export activities, making them a vital link between suppliers and customers in multiple regions. Below, we explore key trade insights, including the major suppliers, products, and destinations.

In many international shipments, Sandoz SA (Pty) Ltd. appears under various similar names due to discrepancies during customs filing. These variations are:

• SANDOZ SA LTD.
• SANDOZ SA PRY LTD.
• SANDOZ SA PTY LTD PO BOX 154200
• SANDOZ SAS.
• SANDOZ SA PTY.
• SANDOZ SAS 49

These name variations reflect the company's widespread engagement in international trade and the complexities involved in multinational shipments.

Procurement Regions and Key Suppliers

Sandoz SA (Pty) Ltd. relies significantly on sourcing pharmaceutical products and raw materials from India, which is a major procurement hub due to the country's strong pharmaceutical manufacturing sector. Below is an overview of their primary suppliers:

• FDC LIMITED
• LUPIN LIMITED
• MEDREICH LIMITED

These suppliers provide essential pharmaceutical components, such as active pharmaceutical ingredients (APIs) and finished dosage forms, contributing to the overall output of Sandoz SA (Pty) Ltd. in terms of generic drug production and other pharmaceutical solutions.

Key Import Products by HS Codes

The main imports of Sandoz SA (Pty) Ltd. include various pharmaceutical ingredients, which are identified by their HS Codes. Here are the most significant imported items:

1. HS Code 293359: Heterocyclic compounds with nitrogen hetero-atom(s) only.
2. HS Code 290514: Various alcohols used in drug manufacturing.
3. HS Code 300410: Medicaments containing penicillins or derivatives thereof.
4. HS Code 300490: Medicaments for therapeutic or prophylactic uses.

The products imported by Sandoz SA (Pty) Ltd. include Cinnarizine EP, Ethambutol Hydrochloride, and Flucloxacillin Capsules. These ingredients are primarily used in anti-bacterial and anti-tuberculosis drugs, catering to global demand for such crucial medication.

Export Operations and Key Destinations

Sandoz SA (Pty) Ltd. is actively involved in exporting pharmaceutical products to various markets. The major destinations for their exports, based on trade volume, include Botswana, India, Lesotho, Namibia, and Turkey. These regions benefit from Sandoz SA (Pty) Ltd.'s comprehensive range of pharmaceutical products, including essential antibiotics and tuberculosis drugs.

Some key products exported by the company include:

• HS Code 300490: Medicaments containing antibiotics.
• HS Code 300420: Medicaments containing other antibiotics.
• HS Code 300410: Penicillin-based medicaments.

The primary exported items include medicaments consisting of mixed or unmixed products for therapeutic use and tuberculosis drugs, ensuring that the company plays a key role in the health and well-being of patients in multiple countries.

Major Export Partners

Sandoz SA (Pty) Ltd. collaborates with several procurement companies around the globe. The significant partners who procure pharmaceutical products from them include:

• DELTA PHARMACEUTICALS (PROPRIETARY) LTD.
• MEDILAND HEALTH CARE DISTRIBUTORS (PROPRIETARY) LTD.
• PREMIER PHARMA TRADE (PROPRIETARY) LTD.
• SANDOZ GRUP SAĞLIK ÜRÜNLERİ İLAÇLARI SANAYİ VE TİCARET ANONİM ŞİRKETİ

These partnerships reinforce Sandoz SA (Pty) Ltd.'s global footprint and emphasize their role in providing critical pharmaceuticals across a diverse market landscape.

Conclusion

Sandoz SA (Pty) Ltd. is a dynamic pharmaceutical entity that maintains a robust global supply chain, from importing vital pharmaceutical ingredients to exporting finished products worldwide. The company's strong sourcing base in India and active exports to regions like Botswana and Turkey showcase their pivotal role in ensuring accessibility to high-quality generics and other pharmaceuticals. Leveraging data insights from NBD DATA, this analysis illustrates how Sandoz SA (Pty) Ltd. is positioned as a significant contributor in the global pharmaceutical supply chain.